Spandidos Publications style
Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, Singer G, Stöhr R, Simon R, Sauter G, Leibiger H, Leibiger H, et al: Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol 25: 641-649, 2004.
APA
Klopocki, E., Kristiansen, G., Wild, P.J., Klaman, I., Castanos-Velez, E., Singer, G. ... Dahl, E. (2004). Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. International Journal of Oncology, 25, 641-649. https://doi.org/10.3892/ijo.25.3.641
MLA
Klopocki, E., Kristiansen, G., Wild, P. J., Klaman, I., Castanos-Velez, E., Singer, G., Stöhr, R., Simon, R., Sauter, G., Leibiger, H., Essers, L., Weber, B., Hermann, K., Rosenthal, A., Hartmann, A., Dahl, E."Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors". International Journal of Oncology 25.3 (2004): 641-649.
Chicago
Klopocki, E., Kristiansen, G., Wild, P. J., Klaman, I., Castanos-Velez, E., Singer, G., Stöhr, R., Simon, R., Sauter, G., Leibiger, H., Essers, L., Weber, B., Hermann, K., Rosenthal, A., Hartmann, A., Dahl, E."Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors". International Journal of Oncology 25, no. 3 (2004): 641-649. https://doi.org/10.3892/ijo.25.3.641
